Top searches

PL

Resources

B2RLaw advises Proteon Pharmaceuticals on a strategic partnership with Skretting

01/02/2021

B2RLaw has advised Proteon Pharmaceuticals on a strategic partnership with Skretting aimed at providing functional solutions to tackle health challenges in the aquaculture industry.

The companies will collaborate on developing products using bacteriophage technology to support aquaculture farmers as part of a holistic health strategy. The companies will work in a parallel R&D pipeline on the project.

The Partnership allows Proteon to grow its product portfolio in aquaculture and expand its presence worldwide. Both Proteon Pharmaceuticals and Skretting predict that the technology will become a valuable component of integrated management strategies on-farm with both feed and water applications under investigation.

Proteon Pharmaceuticals is a Polish originating biotech company with a vision to develop natural feed additives that help remove antibiotics from the food chain and improve animal and human health. The Company uses precision biology for microbiome protection to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.

Norwegian company, Skretting is the world’s largest producer of feeds for farmed fish. The Company has operations on five continents and produces 2.5 million tonnes of feed annually, for more than sixty species of fish. Skretting has 3,500 employees worldwide. Skretting has an R&D unit known as Skretting Aquaculture Research Centre (ARC) with the main objective to provide research and technical support regarding fish and shrimp feed. It has 140 employees representing 25 nationalities.

B2RLaw’s team advising Proteon Pharmaceuticals was led by Partner George Havaris and included Counsels Paulina Wyrostek and Malwina Niczke – Chmura.

George Havaris advises, “Proteon Pharmaceuticals is a Polish company that is well on the path to being a global leader in its field of operation. Animal health is a little-known industry in the wider public eye. However, animal health is fundamental to the health and well-being of humans. We congratulate Proteon and Skretting on this exciting Partnership and we look forward to continuing our support to Proteon on its growth path”.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

01/04/2021

B2RLaw advises Henley Investments on its debut Polish acquisition of a shopping centre

B2RLaw has advised Henley Investments, a leading private equity real estate firm based in the UK, on the acquisition of […]

MORE
23/03/2021

B2RLaw advises specialist international food and agribusiness PE fund on investment

B2RLaw has advised Paine Schwartz Partners, a global leader in investments in the food and agribusiness sectors, on its investment […]

MORE
17/03/2021

B2RLaw launches Agriculture and Agrifood Practice

B2RLaw has launched an Agriculture and Agrifood Practice co-led by Partners Aleksandra Polak and Roman Iwański. In doing so, B2RLaw […]

MORE
11/03/2021

B2RLaw advises on the sale of an office and retail complex in Poznan

B2RLaw has advised an entity from the Wechta Group, one of the largest developers in the Wielkopolski region, on a […]

MORE
04/03/2021

B2RLaw advises PE fund Pinova Capital on the acquisition of software company Raynet GmbH

B2RLaw has advised PE fund Pinova Capital on the Polish aspects of its acquisition of a majority stake of German […]

MORE
02/03/2021

B2RLaw advises Oben Group on its acquisition of plastic packaging group, Poligal

B2RLaw has advised Oben Group on its acquisition of Poligal Group. The acquisition includes BOPP and CPP production plants in […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close